Paradigm-Biocapital-Advisors-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "NUVL",
  "EWTX",
  "INSM",
  "ARQT",
  "RVMD",
  "ARGX",
  "OLMA",
  "IMTX",
  "LENZ",
  "JANX",
  "SYRE",
  "APGE",
  "TARS",
  null,
  "MLTX",
  "ACLX",
  "COGT",
  "ERAS",
  "VRDN",
  "YMAB",
  "PCVX",
  null,
  "CRNX",
  "CYTK",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 27
Total Value: 2172397711
Accession Number: 0001855655-25-000007
Form Type: 13F-HR
CIK: paradigm-biocapital-advisors-lp
Manager Name: Paradigm-Biocapital-Advisors-Lp

Data Enrichment

93% identified

25 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

27 positions • $2.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:6.7M

Value:$25.3M

% of Portfolio:1.2% ($25.3M/$2.2B)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:627.4K

Value:$24.5M

% of Portfolio:1.1% ($24.5M/$2.2B)

Arcutis Biotherapeutics, Inc.

ARQT|03969K108

Shares:1.5M

Value:$22.9M

% of Portfolio:1.1% ($22.9M/$2.2B)

Y-mAbs Therapeutics, Inc.

YMAB|984241109

Shares:4.2M

Value:$18.8M

% of Portfolio:0.9% ($18.8M/$2.2B)

Erasca, Inc.

ERAS|29479A108

Shares:10.8M

Value:$14.8M

% of Portfolio:0.7% ($14.8M/$2.2B)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:1.3M

Value:$9.6M

% of Portfolio:0.4% ($9.6M/$2.2B)

Immatics N.V.

IMTX|N44445109

Shares:1.9M

Value:$8.6M

% of Portfolio:0.4% ($8.6M/$2.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	6.7M	QoQ -7.71% (-563.8K) YoY -14.70% (-1.2M)	All Managers (Combined)	$25.3M	1.2% ($25.3M/$2.2B)	QoQ -40.48% (-$17.2M) YoY -71.66% (-$64.1M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	627.4K	QoQ -64.59% (-1.1M) YoY NEW(+627.4K)	All Managers (Combined)	$24.5M	1.1% ($24.5M/$2.2B)	QoQ -74.45% (-$71.5M) YoY NEW(+$24.5M)
Arcutis Biotherapeutics, Inc.(ARQTcusip03969K108)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$22.9M	1.1% ($22.9M/$2.2B)	QoQ NEW(+$22.9M) YoY NEW(+$22.9M)
Y-mAbs Therapeutics, Inc.(YMABcusip984241109)	4.2M	QoQ 0.00% (-0) YoY +89.66% (-2.0M)	All Managers (Combined)	$18.8M	0.9% ($18.8M/$2.2B)	QoQ -43.42% (-$14.4M) YoY -48.32% (-$17.6M)
Erasca, Inc.(ERAScusip29479A108)	10.8M	QoQ +0.46% (-50.0K) YoY NEW(+10.8M)	All Managers (Combined)	$14.8M	0.7% ($14.8M/$2.2B)	QoQ -45.16% (-$12.2M) YoY NEW(+$14.8M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	1.3M	QoQ NEW(+1.3M) YoY NEW(+1.3M)	All Managers (Combined)	$9.6M	0.4% ($9.6M/$2.2B)	QoQ NEW(+$9.6M) YoY NEW(+$9.6M)
Immatics N.V.(IMTXcusipN44445109)	1.9M	QoQ -64.77% (-3.5M) YoY -32.34% (-911.8K)	All Managers (Combined)	$8.6M	0.4% ($8.6M/$2.2B)	QoQ -77.65% (-$29.9M) YoY -70.96% (-$21.0M)